QA: Merck & Co. Inc. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000310158_2023_Merck_Co_Inc.pdf

Logs

info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0000310158, Merck & Co. Inc.

  xvar xval
0 AssetsCurrent 35,722,000,000
1 IntangibleAssetsNetIncludingGoodwill 41,473,000,000
2 PropertyPlantAndEquipmentNet 21,422,000,000
3 remainder_Assets 10,543,000,000
4 LiabilitiesCurrent 24,239,000,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 17,411,000,000
8 SellingGeneralAndAdministrativeExpense 10,042,000,000
9 ResearchAndDevelopmentExpense 13,548,000,000
10 remainder_Expenses 3,763,000,000
11 remainder_Revenues 59,283,000,000
12 remainder_NetIncome 0
13 remainder_ComprehensiveNetIncome -339,000,000
  yvar yval
0 Assets 109,160,000,000
1 Liabilities 24,239,000,000
2 Expenses 44,764,000,000
3 Revenues 59,283,000,000
4 StockholdersEquity 84,921,000,000
5 NetIncome 14,519,000,000
6 ComprehensiveNetIncome 14,349,500,000
7 BaseVar 118,892,500,000
8 EconomicCapitalRatio 2.41

Edgar->Model Mapping

Feature Distribution

Change over Time